Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies.

Nearly 600K bottles of blood pressure drug recalled due to carcinogen risk
The FDA has detailed three voluntary recalls for prazosin hydrochloride, a medication used to treat hypertension, due to safety concerns.
FDA clears new AI-enabled coronary plaque analysis software
Circle Cardiovascular Imaging, a Canadian medtech company, received the key approval for its cvi42 | Plaque platform.
Mammography services suspended at 2 hospitals following ACR review
A news release indicates the suspensions are due to breast images not meeting the college's clinical quality standards.
Consolidation may be driving radiologists away from practicing as generalists
Radiologists who experienced a practice closure are more likely to operate as subspecialists afterward, according to new Neiman research.
FDA warns Philips after issues arise at multiple manufacturing facilities
Meanwhile, the Amsterdam-based imaging giant said it has already taken action to begin correcting these issues.

FDA issues Class I alert on Philips ventilators after 4 injuries

All serial numbers and lots of several Philips ventilators are at risk for damaged airflow sensors if used with in-line nebulizers.

The rapid rise of artificial intelligence (AI) has helped cardiologists, radiologists, nurses and other healthcare providers embrace precision medicine in a way that ensures more heart patients are receiving personalized care.

FDA clears AI screening tool for cardiac amyloidosis

Ultromics designed EchoGo Amyloidosis to evaluate routine echocardiogram results for signs of cardiac amyloidosis. It received the FDA's breakthrough device designation back in 2023.

Trump selects Emmy-winning TV personality Dr. Oz to head CMS

President-elect Donald Trump announced the nomination of former "Dr. Oz Show" star Mehmet Oz just days after appointing Robert F. Kennedy Jr. as secretary of health.

FDA issues Class I recall of infusion pump batteries due to risk of burns

Rechargeable batteries used on CADD-Solis Li-ion infusion systems may short out if damaged, possibly causing the case to melt. No injuries have been reported.

artificial intelligence AI in healthcare

Industry Watcher’s Digest

Black-box outputs aren’t just a problem with AI. They’re also a problem with physicians.

artificial intelligence AI life sciences biopharma

When life sciences met artificial intelligence

The pace of AI adoption is quickening in the sector, which includes biopharmaceuticals, digital health, clinical diagnostics and medical devices.

DEA, HHS extend telehealth controlled substance prescription rule

The COVID-era flexibility has been extended until 2026 as the DEA and HHS work on a permanent fix that will appease regulators and providers alike.

Radiology at a crossroads: Hopes and concerns for a second Trump administration

In this RB opinion piece, Radiology Business Management Association leaders discuss what President-elect Trump's 2nd term might mean for the specialty.

Policy & Regulations

Nearly 600K bottles of blood pressure drug recalled due to carcinogen risk

FDA clears new AI-enabled coronary plaque analysis software

Mammography services suspended at 2 hospitals following ACR review

Consolidation may be driving radiologists away from practicing as generalists

FDA warns Philips after issues arise at multiple manufacturing facilities